Search icon

CODAGENIX INC.

Company Details

Name: CODAGENIX INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 01 Apr 2009 (16 years ago)
Entity Number: 3793440
ZIP code: 11735
County: Nassau
Place of Formation: Delaware
Address: 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

Commercial and government entity program

CAGE number Status Type Established CAGE Update Date CAGE Expiration SAM Expiration
5D8K5 Active Non-Manufacturer 2009-03-26 2024-09-16 2029-09-16 2025-09-12

Contact Information

POC JEFFREY FU
Phone +1 484-358-6843
Address 3 BIOSCIENCE PARK DR BLDG II STE 501, FARMINGDALE, NASSAU, NY, 11735, UNITED STATES

Ownership of Offeror Information

Highest Level Owner Information not Available
Immediate Level Owner Information not Available
List of Offerors (0) Information not Available

DOS Process Agent

Name Role Address
CODAGENIX INC. DOS Process Agent 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

Chief Executive Officer

Name Role Address
JOHN ROBERT COLEMAN Chief Executive Officer 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

History

Start date End date Type Value
2023-04-06 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer)
2021-04-27 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Service of Process)
2020-11-16 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer)
2020-01-07 2020-11-16 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Principal Executive Office)
2011-05-09 2020-01-07 Address 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Principal Executive Office)
2011-05-09 2020-11-16 Address 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Chief Executive Officer)
2009-04-01 2021-04-27 Address 5211 15TH AVE., BROOKLYN, NY, 11219, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
230406000507 2023-04-06 BIENNIAL STATEMENT 2023-04-01
211220000851 2021-12-20 BIENNIAL STATEMENT 2021-12-20
210427000210 2021-04-27 CERTIFICATE OF CHANGE 2021-04-27
201116002020 2020-11-16 AMENDMENT TO BIENNIAL STATEMENT 2019-04-01
200107061151 2020-01-07 BIENNIAL STATEMENT 2019-04-01
130422002114 2013-04-22 BIENNIAL STATEMENT 2013-04-01
110509002356 2011-05-09 BIENNIAL STATEMENT 2011-04-01
090401000332 2009-04-01 APPLICATION OF AUTHORITY 2009-04-01

USAspending Awards. Contracts

Contract Type Award or IDV Flag PIID Start Date Current End Date Potential End Date
DEFINITIVE CONTRACT AWARD 75A50123C00048 2023-09-30 2024-12-31 2026-07-31
Unique Award Key CONT_AWD_75A50123C00048_7505_-NONE-_-NONE-
Awarding Agency Department of Health and Human Services
Link View Page

Award Amounts

Obligated Amount 10000000.00
Current Award Amount 57630647.00
Potential Award Amount 389449173.00

Description

Title CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE.
NAICS Code 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product and Service Codes AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH

Recipient Details

Recipient CODAGENIX INC.
UEI TEMNL437K2F1
Recipient Address UNITED STATES, 3 BIOSCIENCE PARK DR, FARMINGDALE, SUFFOLK, NEW YORK, 117351019

U.S. Small Business Administration Profile

Status User ID Name of Firm Trade Name UEI Address
Active P1058043 CODAGENIX INC - TEMNL437K2F1 3 BIOSCIENCE PARK DR BLDG II STE 501, FARMINGDALE, NY, 11735-
Capabilities Statement Link -
Phone Number 484-358-6843
Fax Number -
E-mail Address jfu@codagenix.com
WWW Page www.codagenix.com
E-Commerce Website http://www.codagenix.com
Contact Person JEFFREY FU
County Code (3 digit) 059
Congressional District 01
Metropolitan Statistical Area 5380
CAGE Code 5D8K5
Year Established 2009
Accepts Government Credit Card No
Legal Structure Corporation
Ownership and Self-Certifications -
Business Development Servicing Office NEW YORK DISTRICT OFFICE (SBA office code 0202)
Capabilities Narrative Development of new and improved vaccines against infectious diseases. Vaccines against emerging or pandemic pathogens.
Special Equipment/Materials (none given)
Business Type Percentages (none given)
Keywords Vaccines, Research, Development, Clinical, Biotechnology, Biologicals, InfectiousDiseases, Synthetic Biology
Quality Assurance Standards (none given)
Electronic Data Interchange capable -

SBA Federal Certifications

HUBZone Certified No
Women Owned Certified No
Women Owned Pending No
Economically Disadvantaged Women Owned Certified No
Economically Disadvantaged Women Owned Pending No
Veteran-Owned Small Business Certified No
Veteran-Owned Small Business Joint Venture No
Service-Disabled Veteran-Owned Small Business Certified No
Service-Disabled Veteran-Owned Small Business Joint Venture No

Bonding Levels

Description Construction Bonding Level (per contract)
Level $0
Description Construction Bonding Level (aggregate)
Level $0
Description Service Bonding Level (per contract)
Level $0
Description Service Bonding Level (aggregate)
Level $0

NAICS Codes with Size Determinations by NAICS

Primary Yes
Code 541714
NAICS Code's Description Research and Development in Biotechnology (except Nanobiotechnology)
Buy Green Yes

Export Profile (Trade Mission Online)

Exporter Wants
Export Business Activities Manufacturer, Service(s), Other
Exporting to Aruba; Algeria; Albania; Argentina; Australia; Austria; Bahrain; Barbados; Botswana; Bermuda; Belgium; Bahamas, The; Belize; Brazil; Brunei; Canada; Sri Lanka; China; Chile; Cayman Islands; Colombia; Costa Rica; Cyprus; Denmark; Dominica; Dominican Republic; Egypt; Ireland; Estonia; El Salvador; Czech Republic; Finland; Fiji; France; Gabon; Ghana; Grenada; Germany; Greece; Guatemala; Hong Kong; Croatia; Hungary; Iceland; India; Israel; Italy; Japan; Jordan; Korea, Republic of; Kuwait; Lebanon; Latvia; Lithuania; Slovakia; Liechtenstein; Lesotho; Luxembourg; Macau; Montserrat; Monaco; Morocco; Mauritius; Malta; Oman; Maldives; Mexico; Malaysia; Vanuatu; Netherlands; Norway; Netherlands Antilles; New Zealand; Paraguay; Peru; Poland; Panama; Portugal; Qatar; Philippines; Saudi Arabia; St. Kitts and Nevis; Seychelles; South Africa; Slovenia; Singapore; Spain; St. Lucia; Sweden; Switzerland; United Arab Emirates; Trinidad and Tobago; Thailand; Tonga; Tunisia; Turkey; Taiwan; United Kingdom; Uruguay; St. Vincent and the Grenadines; Venezuela; British Virgin Islands; Vatican City; Namibia; Western Samoa; Swaziland; Zimbabwe
Desired Export Business Relationships Direct export sales, Distributor/Importer, Representative/Agent/Broker, Overseas retailers, Licensing, Franchising, Contract manufacturing, Joint venture/coventure, Wholly owned subsidiaries/branches, Alliances, Investment, Other (Please explain below)
Description of Export Objective(s) Technology Transfer, Stategic Partnerships

Date of last update: 27 Mar 2025

Sources: New York Secretary of State